Transarterial Chemoembolization in Therapy of Patients with Recurrence of Hepatocellular Cancer in a Liver Transplant: a Clinical Case

Abstract

Resection and orthotopic liver transplantation are considered radical methods in patients with hepatocellular cancer (HCC). However, recurrence is observed in 6-20 % of patients who have undergone liver transplantation for hepatocellular cancer. In about 20 % of cases there is an local lesion of the transplant, and a combination of intra- and extrahepatic metastasis is observed in at least 30 % of patients. At the time of detection of the recurrence of HCC in the liver transplant, most patients are no longer subject to radical treatment due to the presence of multifocal bilobar liver damage or extrahepatic metastasis. Transarterial chemoembolization (TACE) can be a method of choice, can make it possible long-term local control of the tumor process in the liver transplant.